Fourth Angel

 

When diagnosed with testicular cancer in 1997, Olympic figure skating champion Scott Hamilton identified three "angels" who helped him in his successful fight. His oncology physician was his first angel; his oncology nurse was his second angel; and his family and friends were his third.

What he found missing, however, was a fourth angel—somone who had gone through the same experience and who understood what he was feeling. Someone, in short, who had "been there."

After beating his cancer, Scott set up the 4th Angel Mentoring Program.

Patient Mentors

The 4th Angel Program matches patients with a cancer survivor of a similar background and age who can offer advice and support. Anyone with cancer can be brought together with a mentor. Once a match is made, the mentor will then set up a phone or e-mail correspondence with the patient.

Caregiver Mentors

Mentors are also available for anyone caring for a cancer patient. A caregiver mentor is someone who is currently, or was previously, a caregiver for a cancer patient. 

Mentors call on their life experience to assist others in their journey through cancer. They offer comfort and reassurance to patients and family members, allowing them to express their feelings, talk about their fears, and ask questions of someone who has been in their situation.

For more information on being a patient or caregiver mentor, visit www.scottcares.com.

To have someone from the 4th Angel Network contact you regarding joining the program, please click here. 

 

 

 

Latest Cancer News
ACS Guidelines for Breast Screening with MRI May Be Excluding Some High-risk Women

January 6, 2009 — The American Cancer Society (ACS) has developed a set of guidelines to recommend which high-risk women need to undergo screening with breast magnetic resonance imaging (MRI); however, these guidelines may unwittingly exclude some women who are at a high risk of carrying the BRCA mutation yet still don’t meet the limitations set by the ACS. The results of this study were published in the journal Cancer.

Colonoscopy Fails to Identify Many Colorectal Cancers

January 6, 2009 — Colonoscopy, a standard screening method for colorectal cancer, misses the majority of cancers on the right side of the colon and about one-third of cancers on the left side of the colon, according to the results of a study published in the Annals of Internal Medicine. The researchers estimated that the screening method may reduce colorectal cancer mortality by 60-70%, rather than 90% as previously estimated.

High-dose Faslodex® Improves Time to Progression Compared with Arimidex® as Initial Therapy in Advanced Breast Cancer

January 6, 2009 — Researchers affiliated with an international trial have reported that high-dose Faslodex® (fulvestrant) significantly improves time to cancer progression compared with Arimidex® (anastrozole) as initial therapy for hormone-positive, advanced breast cancer. These results were recently presented at the 2008 annual San Antonio Breast Cancer Symposium December 10-14, 2008.

Select news items provided by Reuters Health
Other Support Groups